Syros Pharmaceuticals Price Performance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Syros pharmaceuticals price performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Syros Pharmaceuticals Price Performance Today - Breaking & Trending Today

Syros Pharmaceuticals (NASDAQ:SYRS) Posts Earnings Results, Beats Expectations By $0.10 EPS

Syros Pharmaceuticals (NASDAQ:SYRS) Posts Earnings Results, Beats Expectations By $0.10 EPS
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Piper Sandler , Syros Pharmaceuticals , Earnings History For Syros Pharmaceuticals , Syros Pharmaceuticals Inc , Syros Pharmaceuticals Price Performance , Syros Pharmaceuticals Company Profile , News Ratings For Syros Pharmaceuticals Daily , Get Free Report , Syros Pharmaceuticals Daily ,

Syros Pharmaceuticals (NASDAQ:SYRS) Receives Overweight Rating from Piper Sandler

Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report)‘s stock had its “overweight” rating reiterated by Piper Sandler in a research note issued on Wednesday, Benzinga reports. They presently have a $13.00 price objective on the stock. Piper Sandler’s price target indicates a potential upside of 166.94% from the stock’s current price. Other analysts have also recently […] ....

Piper Sandler , Virtu Financial , Pricet Rowe Associates Inc , Syros Pharmaceuticals , Syros Pharmaceuticals Price Performance , Syros Pharmaceuticals Inc , News Ratings For Syros Pharmaceuticals Daily , Asset Management Inc , Hightower Advisors , Hedge Funds Weigh In On Syros Pharmaceuticals , Get Free Report , Sigma Investments , Tower Advisors , Management Inc , Syros Pharmaceuticals Daily ,

Syros Pharmaceuticals (NASDAQ:SYRS) Rating Lowered to Sell at StockNews.com

Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday. Syros Pharmaceuticals Price Performance Shares of NASDAQ SYRS traded down $0.10 during mid-day trading on Tuesday, reaching $6.46. The company had a […] ....

Srinivas Akkaraju , News Ratings For Syros Pharmaceuticals Daily , Syros Pharmaceuticals Price Performance , Renaissance Technologies , Syros Pharmaceuticals Inc , Blue Owl Capital Holdings , Institutional Trading Of Syros Pharmaceuticals , Syros Pharmaceuticals , Securities Exchange Commission , Bain Capital Life Sciences Investors , Get Free Report , Director Srinivas Akkaraju , Exchange Commission , Owl Capital Holdings , Capital Life Sciences Investors , Syros Pharmaceuticals Daily , Nasdaq Syrs , Stocknews Com ,

Brookline Capital Management Weighs in on Syros Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:SYRS)

Brookline Capital Management Weighs in on Syros Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:SYRS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Srinivas Akkaraju , Piper Sandler , Insider Transactions At Syros Pharmaceuticals , Syros Pharmaceuticals , Prudential Financial Inc , Syros Pharmaceuticals Inc , Sawtooth Solutions , News Ratings For Syros Pharmaceuticals Daily , Advisor Group , Institutional Trading Of Syros Pharmaceuticals , Walleye Trading , Syros Pharmaceuticals Company Profile , Syros Pharmaceuticals Price Performance , Free Report , Brookline Capital Management , Capital Management , Syros Pharmaceutical , Get Free Report , Director Srinivas Akkaraju , Syros Pharmaceuticals Daily ,

Syros Pharmaceuticals (SYRS) Set to Announce Quarterly Earnings on Tuesday

Syros Pharmaceuticals (SYRS) Set to Announce Quarterly Earnings on Tuesday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Acadian Asset Management , Syros Pharmaceuticals Company Profile , Hermes Inc , Syros Pharmaceuticals Price Performance , News Ratings For Syros Pharmaceuticals Daily , Advisor Group , Topco Ltd , Syros Pharmaceuticals Inc , Syros Pharmaceuticals , Earnings History For Syros Pharmaceuticals , Renaissance Technologies , Institutional Investors Weigh In On Syros Pharmaceuticals , Get Free Report , Asset Management , Syros Pharmaceuticals Daily ,